AUG 12, 2026 · PHASE 3 TRIAL
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
ClinicalTrials.gov
This is a clinical trial registry record describing a completed Phase 3 study design with planned enrollment of 305 participants; no results are reported in this registry entry, only the study structure and primary outcome measure.
Reported
Planned enrollment305
PhasePHASE3
Primary outcome measurepCR Rate at time of surgery